Asphalion’s Board of Directors is pleased to announce the appointment of Marta Rayo Lunar as new Scientific and Regulatory Affairs Director.
Marta has a Bachelor of Science in Pharmacy and postgraduate specialization studies in Industrial Pharmacy and Galenic Formulation. She also holds a Master of Advanced Studies (MAS) in Biopharmacy, Pharmacology and Drug Quality.
She brings over 7 years of experience as R+D Project Manager at a Spanish biotechnology company focused on the development of drug candidates and over 5 years working in Regulatory Affairs in drug product development activities of new chemical drugs and biologics (including biosimilars and ATMPs).
Furthermore, she has extensive experience in scientific medical writing of regulatory documents for CTAs, Scientific Advice Procedures, Orphan Drug Designations (EU and FDA), as well as in scientific medical writing of Clinical Evaluation Reports for Medical Device’s regulatory documents.
“When I joined Asphalion, I never thought it could be such an exciting journey, always at the forefront of innovation for the benefit of our customers. I am very grateful for this great opportunity to continue growing professionally and I accept the challenge with enthusiasm and commitment, especially for Asphalion´s people”.
Our team possesses strong technical knowledge and long experience in the industry to help our clients in any challenge. We are very confident that with Marta´s leadership we will deliver great value, support and innovation to our customers. The growth of our team is intrinsically linked to that of our clients: We aim to keep growing together and envision a great future ahead.
We would like to thank Marta for embracing this challenge.
About us
Asphalion is an international Scientific and Regulatory Affairs consultancy company with offices in Barcelona, Madrid, Munich and London. Founded in 2000, it has consistently grown, and now employs more than 100 team members from 12 different nationalities with backgrounds in Pharmacy, Chemistry, Biology, Biochemistry, Biotechnology and Medicine. Asphalion collaborates with Pharmaceutical, Biotechnological and Medical Technology organizations facilitating product development and regulatory affairs solutions for their projects.
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
